CoChat

Clinical evaluation of total and high-avidity anti-dsDNA antibody assays for the diagnosis of systemic lupus erythematosus

Yuan, W, Cao, H, Wan, P, Shi, R, Zhou, S, Zheng, J · 2019 · Lupus

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

Background: This study evaluated the diagnostic performances of total and high-avidity (HA) anti-dsDNA enzyme immunoassays (EIA) in Chinese systemic lupus erythematosus (SLE) patients. Methods: A total of 410 serum samples from 217 SLE patients, 54 patients with other systemic autoimmune diseases, and 139 healthy subjects were tested on total and HA anti-dsDNA EIA, as well as three commercial in vitro diagnostic kits: BioPlex 2200 ANA Screen, Kallestad anti-dsDNA EIA, and Crithidia Lucilae IFA. The disease activities of SLE patients were assessed using the modified SLE Disease Activity Index. The diagnostic performances of each assay were analyzed using Analyse-it software. Results: The diagnostic performances of the total and HA anti-dsDNA EIA kits were comparable to other commercially available in vitro diagnostic assays. Receiver operating characteristic curve analysis demonstrated an area under the curve ranging from 0.85 to 0.89, with the total anti-dsDNA kit demonstrating the highest sensitivity and the HA kit showing higher specificity. An overall agreement of >90% was observed between the total and HA anti-dsDNA EIA kits and commercially available quantitative anti-dsDNA kits. The ratio of HA to total anti-dsDNA antibody was significantly higher among SLE patients with active disease status and/or kidney damage. All assays exhibited a significant correlation with disease activity and multiple clinical manifestations. Conclusions: While the clinical performances of various anti-dsDNA assays showed adequate agreements, the BioPlex 2200 anti-dsDNA assay demonstrated the highest positive likelihood ratio and odds ratio. The HA anti-dsDNA EIA kit in association with the total anti-dsDNA kit provided superior performance in SLE diagnosis and monitoring disease activity.

Overview

Integrity signals

Registry

Crossref · 10.1177/0961203319877243

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 41 references

Research works printed but not linked: 4

  1. Neogi T, 2006, J Rheumatol, 33, 72
  2. Ghirardello A, 2011, Clin Exp Rheumatol, 29, 50
  3. Smeenk RJ, 2002, Clin Exp Rheumatol, 20, 294
  4. Suh-Lailam BB, 2011, Int J Clin Exp Pathol, 4, 748

Cited by

See all 15

Metadata

Authors
Yuan, W., Cao, H., Wan, P., Shi, R., Zhou, S., & Zheng, J.
Affiliations
  • Shanghai Jiao Tong University (CN)
  • Bio-Rad (United States) (US)
Corresponding author
  • Zhou, S
  • Zheng, J
Venue
Lupus
Published
2019-09-30
Volume
28
Issue
12
Pages
1387-1396
ISSN
  • 0961-2033 (ISSN-L)
  • 1477-0962
OpenAlex
W2979088984
Cited by
15
References
41
Citations by year
2026: 3 · 2025: 3 · 2023: 3 · 2022: 1 · 2021: 4 · 2020: 1
FWCI
1.14
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Lupus (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Key Clinical Specialty (2012649)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
  • Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
Keywords
systemic lupus erythematosus, anti-dsDNA antibodies, enzyme immunoassay, diagnostic accuracy, disease activity, kidney injury, Chinese patients
MeSH terms
Adult, Aged, Antibody Affinity, Antibodies, Antinuclear, Autoantibodies, Autoimmune Diseases, Female, Humans, Lupus Erythematosus, Systemic, Male, Middle Aged, Reagent Kits, Diagnostic, Sensitivity and Specificity, Asian People

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical evaluation of total and high-avidity anti-dsDNA antibody assays for the diagnosis of systemic lupus erythematosus. https://app.cochat.ai/papers/10.1177/0961203319877243
The paper
Yuan, W., Cao, H., Wan, P., Shi, R., Zhou, S., & Zheng, J. (2019). Clinical evaluation of total and high-avidity anti-dsDNA antibody assays for the diagnosis of systemic lupus erythematosus. Lupus. https://doi.org/10.1177/0961203319877243

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.